Additionally, a novel ROS1-ADGRG6 rearrangement induced by the fusion of exons 1–33 of ROS1 on chr6 to exons of 2–26 of ADGRG6 on chr6 has been previously reported in lung cancer (Xu et al., 2019). Here, ADGRG6 is linked to lung carcinoma.